Harvest Fund Management Co., LTD Repligen Corp Transaction History

Harvest Fund Management Co., LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $79,305 - $126,916	-492 Reduced 98.6%	7 $1,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $79,228 - $97,430	-320 Reduced 39.07%	499 $130,000
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $134,391 - $223,704	690 Added 534.88%	819 $236,000
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $45,272 - $56,791	-251 Reduced 66.05%	129 $25,000
Q4 2020 Feb 10, 2021	SELL	$148.08 - $206.57 $82,036 - $114,439	-554 Reduced 59.31%	380 $72,000
Q3 2020 Nov 04, 2020	BUY	$122.51 - $158.27 $50,474 - $65,207	412 Added 78.93%	934 $149,000
Q2 2020 Aug 12, 2020	SELL	$94.33 - $140.48 $118,667 - $176,723	-1,258 Reduced 70.67%	522 $64,000
Q1 2020 May 08, 2020	BUY	$84.96 - $109.14 $151,228 - $194,269	1,780 New	1,780 $171,000

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.